Meeting scheduled for insulin degludec and insulin degludec/insulin aspart
06:21 EDT 18 Jul 2012 | European Pharmaceutical Review
Meeting scheduled to discuss the NDA for the ultra-long-acting insulin degludec & insulin degludec/insulin aspart....
Original Article: Meeting scheduled for insulin degludec and insulin degludec/insulin aspart
More From BioPortfolio on "Meeting scheduled for insulin degludec and insulin degludec/insulin aspart"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
